Johnson & Johnson subsidiary escapes Canadian probe

Canada’s antitrust authority has dropped its abuse of dominance investigation into Janssen, as it could not prove the pharmaceutical company’s conduct hurt competition in the biosimilar drug market.


Get unlimited access to all Global Competition Review content